Jordana Joy, Editor

Catch up on what happened in optometry during the week of May 27-May 31.

The company’s initiatives include involvement with the Global Myopia Awareness Coalition and discounting blue light screen protectors and its pediatric eye care program, among others.

The COAST and ShORe trials have a total of 1984 patients enrolled for the treatment of wet age-related macular degeneration.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

Catch up on what happened in optometry during the week of May 20-May 24.

The Tono-Vera Tonometer allows for automated IOP measurements and eliminates the need for a topical anesthetic.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Christina Schiller, OD, Blake Jarrard, OD, and Christopher Herring, OD, were this year’s recipients.

Reed, OD, will take on the acting president role for the next two months and will be instated as president during this year's Optometry's Meeting.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

South Dakota’s newest scope expansion bill, signed into law earlier this year, offers new opportunities for optometrists.

Michael Belin, MD, weighs the ABCD and Amsler-Krumeich classifications and proposes ABCD progression displays as an effective modern alternative.

Phase 3 trials continue to investigate the efficacy of EpiSmart, a new method of cross-linking that could be utilized in the treatment of keratoconus.

DF-003 is a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1), an inhibitor believed to be responsible for causing ROSAH syndrome.

The program allows practices to sign up for rebate deals and discounted services.

Kourtney Houser, MD, and Kendall Donaldson, MD, MS, give an overview of the important role topography and tomography play in catching keratoconus early in their patients.

Annual follow-ups for patients with keratoconus can help them become better candidates for cross-linking procedures, according to William Trattler, MD.

Early diagnosis of keratoconus is vital given the disease's prevalence in pediatric patient, according to Jennifer Harthan, OD, FAAO, FSLS.

Shelley Cutler, OD, FAAO, comments on technological advancements leading to the progression of keratoconus diagnosis and treatment options during this year's IKA symposium.

Catch up on what happened in optometry during the week of May 13-May 17.

The SCANLY Home OCT device allows physicians to monitor patients’ wet age-related macular degeneration in between visits through a health cloud portal.

The microemulsion drug ocular penetration system platform technology was found to effectively formulate and deliver lipophilic molecules via topical eye drops.

The company reported that statistically significant data was found supporting ANX007’s ability to provide vision loss protection in patients with geographic atrophy.

The clinical-stage biopharmaceutical company has enrolled 15 participants in its study to assess the safety and tolerability of ACT107 in 3 dose strengths.

Conditionally accepted by the FDA as EYO-1901, DURAVYU is a tyrosine kinase inhibitor intended to improve signs and symptoms of non-proliferative diabetic retinopathy in the PAVIA trial.

The diagnostic aid platform, C.DIAG, utilizes artificial intelligence to assist with the diagnosis and treatment of dry eye disease.

Neda Gioia, OD, CNS, FOWNS, CFMP, details recent findings on the efficacy of the NutriTears supplement on dry eye symptoms.

Kelsey Roelofs, MD, gives her best methods to identifying and diagnosing thyroid eye disease in her Controversies in Modern Eye Care 2024 presentation.

Deborah Ristvedt, DO, details her CIME 2024 presentation on new glaucoma management options, led alongside Inder Paul Singh, MD, Arsham Sheybani, MD, and Melissa Tawa, OD, FAAO.

Arjan Hura, MD, gives an overview on a captivating retina panel and other enticing items at the CIME 2024 meeting.